Jonathan Wofford is responsible for the continued development of WellSky’s biotherapies solutions. He has extensive background in the fields of hematopoietic cell transplant and cellular therapy, applying statistical theory to evaluate the safety, purity, and potency of these therapies. Prior to joining WellSky, he spent over a decade as the bioinformatics lead for Cardinal Glennon Children’s Medical Center, the St. Louis Cord Blood Bank, and was a member of the transplant committee for St. Louis University Medical Center. His work has been presented at and published in leading industry conferences and journals. Jonathan was honored by the Center for International Blood and Marrow Transplant Research (CIBMTR) for outstanding clinical research and has presented to members of the United States Congress to advance the use of adult stem cells and to secure funding for the National Marrow Donor Program (NMDP). He’s served on industry committees working to standardize data collection and the evaluation of transplant protocols and patient outcomes. Prior to entering the field of stem cell medicine, he designed disease management programs and analytical models for a major health management organization.